Latest Integral membrane proteins Stories
Researchers at the Department of Psychiatry and Psychotherapy of the University Medical Center of Johannes Gutenberg University Mainz (JGU) have recently gained new insights into treating Alzheimer's disease.
Phase II/III trial of AZD3293, an oral potent small molecule inhibitor of BACE, aims to enroll more than 1,500 patients in 15 countries INDIANAPOLIS, Dec.
Babies start breathing in the womb, inhaling and exhaling irregularly at first, and then gradually more and more, until the day when they’re born and have to do it all the time. But premature babies sometimes have trouble.
-Discovery of Novel Investigational Drug Candidates that Interact with sigma-2/PGRMC1 Receptor Offer Potential to Stop and Reverse Memory Loss in Alzheimer's Patients - PITTSBURGH,
Sterlitech Corporation Offers the Innovative Aquaporin Forward Osmosis Membrane Kent, WA (PRWEB) October 28, 2014 Sterlitech Corporation, a leading manufacturer
Neurotrope's Collaborator BRNI, Publishes Article in the Journal of Alzheimer's Disease describing correlation of PKCe levels and degree of disease PLANTATION, Fla., Aug.
- New Brain Protein Connected for First Time to Cognitive Decline and Alzheimer's Disease. COPENHAGEN, Denmark, July 16, 2014 /PRNewswire-USNewswire/ -- Results from four research studies reported
Using spider toxins to study the proteins that let nerve cells send out electrical signals, Johns Hopkins researchers say they have stumbled upon a biological tactic that may offer a new way to protect crops from insect plagues in a safe and environmentally responsible way.
Study Results Presented at the Alzheimer's Association International Conference 2014 INDIANAPOLIS, July 13, 2014 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced results